Navigation Links
Osteoarthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/25/2011

Profiles of Commonly Used Products in the OA Therapeutics Market 52

5.2.1 Celebrex (celecoxib) 52

5.2.2 Cymbalta (duloxetine hydrochloride) 53

5.2.3 Hyalgan (sodium hyaluronate) 54

5.2.4 Nucynta (tapentadol) 55

5.2.5 Voltaren Gel (diclofenac sodium topical gel 1%) 56

5.3 Key Takeaway 57

6 OA Therapeutics Market: Pipeline Assessment 58

6.1 Overview 58

6.2 Strategic Pipeline Assessment 58

6.2.1 OA Therapeutics – Molecules in Pre-Registration 60

6.2.2 OA Therapeutics – Phase III Pipeline 60

6.2.3 OA Therapeutics – Phase II/III Pipeline 61

6.2.4 OA Therapeutics – Phase II Pipeline 61

6.2.5 OA Therapeutics – Phase I/II Pipeline 62

6.2.6 OA Therapeutics – Phase I Pipeline 62

6.2.7 OA Therapeutics – Preclinical Pipeline 63

6.2.8 OA Therapeutics – Discovery Pipeline 64

6.3 OA Pipeline by Mechanism of Action 65

6.4 OA Technology Trends Analytical Framework 67

6.5 OA Therapeutics – Promising Drugs under Clinical Development 69

6.6 Molecule Profile for Promising Drugs under Clinical Development 70

6.6.1 Cartistem 70

6.6.2 Civanex (civamide, zucapsaicin) 70

6.6.3 Strontium Chloride Hexahydrate (2PX) 71

6.6.4 Oral Salmon Calcitonin (SMC021) 72

6.6.5 BEMA Buprenorphine 72

6.6.6 IP 880 and IP 889 73

6.7 Key Takeaway 73

7 Osteoarthritis Therapeutics – Clinical Trials Mapping 74

7.1 Clinical Trials by Country (US, EU5 and Japan) 74

7.2 Clinical Trials by Phase 75

7.3 Clinical Trials by Trial Status 76

7.4 Prominent Sponsors 77

7.5 Top Companies Participating in OA Therapeutics Clinical Trials 80

8 Osteoarthritis Therapeutics: Strategic Assessment 82

8.1 Osteoarthritis Therapeutics: Implications for Future Market Competition 82

9 Osteoarthritis Therapeutics: Future Playe
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Fidia Farmaceutici S.p.A. to Distribute and Promote HYALGAN® (sodium hyaluronate) for Treatment of Osteoarthritis
2. Actress Jane Kaczmarek Teams Up With DePuy Orthopaedics to Launch Osteoarthritis Awareness and Education Program
3. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
4. Former NBA Star Allan Houston Joins "Apply Yourself!" Campaign to Raise Awareness of Osteoarthritis Hand and Knee Pain
5. The Disease Modifying Effect of Chondroitin Sulphate in Patients With Knee Osteoarthritis Has Been Confirmed by MRI
6. Carbylan BioSurgery Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued
7. Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain
8. Logical Therapeutics Initiates Enrollment in New Gastrointestinal Safety Study in Osteoarthritis Patients
9. Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis
10. Panel of Osteoarthritis Experts Develops Optimal Profile of Exogenous Hyaluronic Acid
11. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Corporation (NASDAQ: CYTR ), a biopharmaceutical research and ... for the three months ended June 30, 2015, and ... milestones for its clinical development programs. "The ... CytRx. Enrollment in our ongoing pivotal global Phase 3 ... continues on track to be completed in the first ...
(Date:8/3/2015)... 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) ... Quarter 2015 Investor Conference Call and webcast at 4:30 p.m., ... call will cover an update on Merrimack,s progress as ... A press release detailing the information to be discussed ... Monday, August 10. Investors and the general public are ...
(Date:8/3/2015)... Aug. 3, 2015  Celsion Corporation (NASDAQ: ... host a conference call to discuss its second ... on its development programs for ThermoDox®, its proprietary ... acquired technology platforms, TheraPlas™ and TheraSilence™, in immunotherapy ... Monday, August 10, 2015. To participate in the ...
Breaking Medicine Technology:CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2
... 29, 2011 Robbins & Myers, Inc. ... sale of its Romaco businesses to a group of ... private equity investment firm.  Total consideration was approximately euro ... of cash and euro 4 million of assumed liabilities ...
... SILVER SPRING, Md., April 29, 2011 Don,t let expired ... dispose of them properly to prevent them from harming others. ... part in the second annual National Prescription Drug Take-Back Day, ... View a slideshow and read a Consumer Update ...
Cached Medicine Technology:
(Date:8/4/2015)... ... August 04, 2015 , ... Oriental ... and crafts, toys, novelties, and school supplies, has developed engaging and affordable teacher ... exclusive collection includes student rewards, classroom decorations, crafts and educational resources featuring ...
(Date:8/4/2015)... ... August 04, 2015 , ... It is National Psoriasis Awareness Month, and we ... symptoms such as dry, itching, burning or soreness of skin that may crack or ... they find what’s right for them. Then, what is effective may stop working, so ...
(Date:8/4/2015)... York, NY (PRWEB) , ... August 04, 2015 , ... ... all but universal, though the desire for invasive surgery to achieve this ideal is ... offer the results people crave without the high cost or lengthy recovery time, according ...
(Date:8/4/2015)... ... ... Nathan’s Famous was recently featured on NewsWatch as part of ... an impact in their industry. Andrew Tropeano, the host of NewsWatch and business expert, ... now offers a 50% Reduced Fat All-Beef Frank variety and is celebrating summer ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... developing the most recent episode which spotlights treating depression. Depression affects millions of ... disease, "In America" wants to inform and enlighten viewers with the latest segment ...
Breaking Medicine News(10 mins):Health News:Oriental Trading Company Brings The World of Eric Carle Characters to Educators Through Classroom Supplies 2Health News:Oriental Trading Company Brings The World of Eric Carle Characters to Educators Through Classroom Supplies 3Health News:USA Medical Card Offers a Solution During National Psoriasis Awareness Month 2Health News:USA Medical Card Offers a Solution During National Psoriasis Awareness Month 3Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 2Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 3
... in the middle ear, a condition called otitis media with ... antihistamines and decongestants, a new review of studies has found.// ... alleviating symptoms or avoiding complications of OME and expose children ... ,"This review finds no benefit for any of the short- ...
... the hepatitis C virus during the first part of 1990, ... hospital which was not sufficiently screened for safety. ,Following ... test for Hepatitis C came out into the open. ... screening for any liver condition. ,The Labor Party's ...
... exploits are titillated by personality traits, contemplates a new ... The idea that personality types may increase the susceptibility ... ,Researchers at the University of Chicago have ... for cancer as compared to the rats that portrayed ...
... researchers, stress among youth associated with parental separation and ... at the John Moores University in Liverpool have found ... parents in recognizing the physical and emotional changes in ... and mental health. ,According to them, there ...
... exhaust of diesel trucks constitute a major contributor to ... children// in the South Bronx, according to the results ... University’s School of Medicine and Robert F. Wagner Graduate ... the study, asthma symptoms, particularly wheezing, doubled among elementary ...
... have found the brain’s natural antioxidant defense mechanism to ... ,According to the researchers at the Dana-Farber Cancer ... harmful effects of toxic ‘free radicals’ that are the ... with aging and certain degenerative brain diseases, heart attack, ...
Cached Medicine News:Health News:Allergy Drugs More Harmful Than Helpful for Chronic Ear Inflammation 2Health News:Allergy Drugs More Harmful Than Helpful for Chronic Ear Inflammation 3Health News:Stress brings about early onset of puberty 2Health News:Asthma Symptoms Linked to Soot from Diesel Trucks in So. Bronx 2Health News:Asthma Symptoms Linked to Soot from Diesel Trucks in So. Bronx 3
The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3....
... Maximum, Maximum Xtra, and Maximum ACT ... standard and specialty hemostasis introducers in ... the premier hemostasis introducers for use ... including angiography, angioplasty, stenting, atherectomy, temporary ...
St. Jude Medical's line of guiding introducers includes Swartz Series, SAFL, SEPT, CSTA, RAMP, and 2 piece steerable...
Rapid Exchange Stent Delivery System with Hepacoat...
Medicine Products: